Trial intelligence / Profile preview

Use of the placebo effect in atopic dermatitis: enhancing pharmacological antipruritic effects via classical conditioning and expectation

2008-008474-31Phase 4Completed

Sponsor
Charité – Universitätsmedizin Berlin
Start
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of histamine in atopic dermatitis (AD) (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Change in itch intensity. Started Jun 2009; status: completed.

02

Drugs

histamine
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on 2008-008474-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-008474-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call